Arcus Biosciences Funding & Investors
Arcus Biosciences, Inc. operates as a biotechnology company. The Company discovers, develops, and commercializes immunotherapies for the treatment of cancer patients. Arcus Biosciences serves customers in the United States.
arcusbio.comTotal Amount Raised: $967,049,984
Arcus Biosciences Funding Rounds
Series B
$70,000,000
Series B Investors
GVInvusDroia VenturesStanford UniversityColumn GroupForesite CapitalNovartisCelgeneTaiho VenturesRTA CapitalPost Ipo Equity
$320,000,000
Post Ipo Equity Investors
Gilead SciencesPost Ipo Equity
$220,350,000
Post Ipo Equity Investors
Gilead SciencesPost Ipo Equity
$200,000,000
Post Ipo Equity Investors
Gilead SciencesSeries C
$107,000,000
Series C Investors
GVEcoR1 CapitalWellington ManagementHillhouse InvestmentInvusForesite CapitalLeerink PartnersCelgeneTaiho VenturesAisling CapitalDroia VenturesDecheng CapitalBiotechnology Value FundColumn GroupSeries A
$49,700,000
Series A Investors
CelgeneColumn Group
Funding info provided by Diffbot.